1. Home
  2. SPCB vs GRI Comparison

SPCB vs GRI Comparison

Compare SPCB & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPCB
  • GRI
  • Stock Information
  • Founded
  • SPCB 1988
  • GRI 2018
  • Country
  • SPCB Israel
  • GRI United States
  • Employees
  • SPCB N/A
  • GRI N/A
  • Industry
  • SPCB Semiconductors
  • GRI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPCB Technology
  • GRI Health Care
  • Exchange
  • SPCB Nasdaq
  • GRI Nasdaq
  • Market Cap
  • SPCB 31.4M
  • GRI 3.4M
  • IPO Year
  • SPCB N/A
  • GRI N/A
  • Fundamental
  • Price
  • SPCB $6.35
  • GRI $6.49
  • Analyst Decision
  • SPCB Strong Buy
  • GRI Strong Buy
  • Analyst Count
  • SPCB 1
  • GRI 2
  • Target Price
  • SPCB $18.00
  • GRI $195.50
  • AVG Volume (30 Days)
  • SPCB 295.9K
  • GRI 13.5K
  • Earning Date
  • SPCB 04-21-2025
  • GRI 03-27-2025
  • Dividend Yield
  • SPCB N/A
  • GRI N/A
  • EPS Growth
  • SPCB N/A
  • GRI N/A
  • EPS
  • SPCB 1.02
  • GRI N/A
  • Revenue
  • SPCB $26,843,000.00
  • GRI N/A
  • Revenue This Year
  • SPCB $6.72
  • GRI N/A
  • Revenue Next Year
  • SPCB $16.91
  • GRI N/A
  • P/E Ratio
  • SPCB $6.93
  • GRI N/A
  • Revenue Growth
  • SPCB 5.23
  • GRI N/A
  • 52 Week Low
  • SPCB $2.55
  • GRI $5.13
  • 52 Week High
  • SPCB $18.95
  • GRI $202.22
  • Technical
  • Relative Strength Index (RSI)
  • SPCB 35.00
  • GRI 30.09
  • Support Level
  • SPCB $7.39
  • GRI $6.02
  • Resistance Level
  • SPCB $7.97
  • GRI $7.58
  • Average True Range (ATR)
  • SPCB 1.13
  • GRI 1.11
  • MACD
  • SPCB -0.40
  • GRI -0.01
  • Stochastic Oscillator
  • SPCB 0.46
  • GRI 9.53

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist, for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

Share on Social Networks: